Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer.

Alavi, Ali; Izadpanahi, Mohammad-Hosein; Haghshenas, Leila; Faridizad, Romina; Eslami, Mohammad-Javad; Ghadimi, Keyvan

Alavi, Ali; Izadpanahi, Mohammad-Hosein; Haghshenas, Leila; Faridizad, Romina; Eslami, Mohammad-Javad; Ghadimi, Keyvan.

Afiliación

Alavi A; Department of Research, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Izadpanahi MH; Department of Urology, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Haghshenas L; Department of Molecular and Cellular Biology, International University of Spain Spain.
Faridizad R; Department of Research, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Eslami MJ; Department of Research, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Ghadimi K; Department of Research, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.

Int J Physiol Pathophysiol Pharmacol ; 11(6): 289-292, 2019.

Article en En | MEDLINE | ID: mdl-31993104

Palabras clave

BLCA-4; bladder; malignancy; urine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Screening_studies Idioma: En Revista: Int J Physiol Pathophysiol Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google